Annual Report 04

Total Page:16

File Type:pdf, Size:1020Kb

Annual Report 04 iProstate Cancer Foundation Annual Report 04 1250 Fourth Street Santa Monica, California 90401 Tel 310.570.4700 Fax 310.570.4701 www.prostatecancerfoundation.org Donations Please mail your check to: Prostate Cancer Foundation 1250 Fourth Street Santa Monica, California 90401 To make an online contribution, please visit our Web site: prostatecancerfoundation.org. To make a credit card donation, call 800.757.CURE. Memorial or Tribute Gifts Honor the memory of a loved one or celebrate the accomplish- ment of a friend or family PCF member by helping others. 2004 WAS A REMARKABLE YEAR. Make a memorial or tribute gift and the PCF will send an Fortune featured the PCF in its November cover story acknowledgment card to the entitled “Beating Cancer,” and named the PCF as its offi cial family of the honoree. philanthropy to celebrate its 75th anniversary. Other Gift Suggestions For the fi rst time ever, the U.S. Food and Drug Adminis- tration approved a drug (Taxotere) that extends life for men Assets or property including with advanced prostate cancer. appreciated stock and real estate. The PCF expanded its donor base by 35%. Bequest—Include a gift to the PCF in your will. And, signifi cant progress was made in demonstrating the link between nutrition, especially antioxidants, and Name the PCF as the primary prostate cancer. or contingent benefi ciary on a life insurance policy. Editors: Sarah Evans, Jessica Niebauer Contributor: Jon Greer Special Thanks: Aaron Ciechanover, M.D., D.Sc., Steve Burd, Don Coffey, Ph.D. , Rosey Grier, Beth Kobliner Shaw, Nelson Peltz, Marvin R. Shanken, Wade F.B. Thompson, Joe Torre Photography: Michael D’Ambrosia Design: KBDA, Los Angeles More information: www.prostatecancerfoundation.org Fortune magazine noted the PCF and Mike Milken have… “…managed to raise the profi le of prostate cancer signifi cantly, increase funding dramatically to fi ght the dis- ease, spur innovative research, attract new people to the fi eld, get myriad drugs into clinical trials, and dare we say, speed up science.” November 29, 2004 2Prostate Cancer Foundation DEAR FRIENDS Last spring, Fortune magazine arrived on our desks with a dispiriting cover story titled “Why We’re Losing the War on Cancer.” The article argued that the “cancer establishment” was wasting time and resources while millions of cancer patients were left waiting for new treatments and a cure for their disease. While we respected Fortune’s took our advice, and the We have funded more than analysis, it simply didn’t resulting cover story ran in 1,200 prostate cancer research square with what we were November 2004 under the projects at more than 100 experiencing at the Prostate headline “Beating Cancer.” institutions worldwide. We Cancer Foundation. Here, have successfully advocated Harnessing Our Power we saw the best and brightest for massive increases in federal researchers making real strides At the PCF, we are doing funding for prostate cancer in understanding this disease everything in our power to research, leveraging your con- and testing new treatments. beat cancer. Starting a little tributions many times over. We were identifying visionary more than a decade ago, we Moreover, we have contin- leaders working relentlessly to turned the “cancer establish- uously worked to clear the remove roadblocks to the de- ment” on its ear, transforming barriers to successful prostate velopment of better treatments prostate cancer research from cancer research. We have and potential cures. And, we a backwater into one of the established novel alliances were researching treatments most important areas of cancer among research institutions and lifestyle changes available research. We have raised more and bridged the gap between to patients right now, helping than $230 million from major clinicians in the various medi- many live longer. donors, corporations, leading cal disciplines, providing them brands and individuals to We felt so strongly, in fact, that with valuable insight into the fund prostate cancer research, we suggested to Fortune that research process and gaining quickly establishing the PCF they do a follow-up story on their help in speeding prostate as the world’s leading phil- the success of the PCF. They anthropic source of support for prostate cancer research. 3 cancer treatments through through the clinical pipeline the development process. toward regulatory approval. We have opened doors to key In 1993, men without prostate government offi cials, provid- cancer didn’t have their pros- ing them with information tate specifi c antigen (PSA) and support to both rally levels routinely checked governmental resources and because the test wasn’t even reduce bureaucratic barriers. approved as a preventive screening method. Today, Achieving Results tens of millions of men have In 2004, we issued the fi rst- their PSA levels checked, ever Report to the Nation on allowing physicians to catch Today, breakthroughs in Prostate Cancer, in which 24 prostate cancer at very early prostate cancer research seem prostate cancer thought leaders stages while also increasing to happen almost daily, with outlined the state of the art in treatment options. new reports streaming out the diagnosis, treatment and Today, breakthroughs in about advances in drug devel- prevention of prostate cancer prostate cancer research seem opment, treatment options, and laid out a clear agenda to happen almost daily, with diagnostic capabilities and for future progress. new reports streaming out new lifestyle choices. The results? We are fi ghting about advances in drug devel- cancer in meaningful ways. opment, treatment options, In 2004, an estimated 30,000 diagnostic capabilities and men died of prostate cancer, new lifestyle choices. A recent a 26% decrease in prostate pinnacle of scientifi c achieve- cancer deaths from 1993, ment was reached with the when the PCF was founded. awarding of the 2004 Nobel In 1993, there were fi ve Prize in Chemistry to Aaron approved drugs for treating Ciechanover, M.D., D.Sc., a prostate cancer. Today there recipient of multiple PCF are 13 approved drugs, with research grants, to support many more making their way his award-winning research into the proteasome, which regulates the abundance of key proteins involved in cell survival. 4 Prostate Cancer Foundation A Team Effort are likely to die from prostate This year, we urge you cancer in 2005. Moreover, to act and help the Prostate Indeed, it’s a very exciting with the aging of the baby Cancer Foundation continue time to be working on your boomer generation, we await to beat cancer. behalf to fi nd better treat- a wave of new prostate cancer ments and an ultimate cure Sincerely, cases, upwards of 300,000 a for recurrent prostate cancer. year by 2015, and a death rate We have been joined in our spiraling up to 50,000 men Michael Milken work by an impressive lineup per year. Founder and Chairman of supporters, including Major League Baseball, Safeway, These sobering statistics eBay, AriZona Beverages, guide us in everything we do. Yahoo!, News Corp., Hugo If we are to continue to beat Boss and many more. We prostate cancer, we will have have persuaded the two most to marshal far more resources populous states in the U.S., and persuade many more New York and California, to people to join our cause. include a tax-form check-off That’s why we continue to to support prostate cancer. need your help. We’re doing Leslie D. Michelson We have generated a wave of Vice Chairman and everything we possibly can, publicity about our cause with Chief Executive Offi cer around the clock, to beat the help of NBC’s Today show; cancer—raising funds, sup- our “Act. Like a Man.” public porting researchers, breaking service advertising campaign, down barriers, creating produced by TBWA\Chiat\ alliances—but to do more, Day; and, yes, a cover story we must have your help. in Fortune magazine. You Must Act Yet we stay focused on our goal, and for a very good With your generous support, reason: In 2005, an estimated we can fund more of the 232,000 men will be diag- many worthy research grant nosed with prostate cancer. requests that arrive at our Despite all our achievements offi ces every day. With your to date, another 30,000 men help, we will continue to clear the scientifi c and bureaucratic hurdles that impede progress and cause needless suffering. We can’t do it alone. It’s as simple as that. To beat prostate cancer once and for all, we must leverage the talents and resources of thousands of people and institutions around the world. Collaboration, cooperation and teamwork have been hallmarks of the PCF from the start, and they remain important components of the PCF’s ongoing strategy. Our sup- porters include the people featured in this report—men with prostate cancer, loved ones and others who simply care. Join us. 6Prostate Cancer Foundation PROSTATE CANCER Cancer of the prostate is the most common non-skin cancer STATUS UPDATE in America. One in six American men will be diagnosed with prostate cancer. A man is 33% more likely to get prostate cancer than a woman is to get breast cancer. Prostate cancer is a scourge—it attacks millions of men as they age. Last year, 232,000 men received a prostate cancer diagnosis, and the disease took the lives of some 30,000 men, including the famous—Law & Order’s Jerry Orbach, Citigroup’s Walter Wriston, legendary guitarist Johnny Ramone—as well as everyday loved ones—someone’s father, son, brother, friend. The prostate is no bigger than a walnut, yet it plays a key role in the male reproductive system. Located in a hard-to-reach place between the penis and the bladder, it is unusually susceptible to cancer.
Recommended publications
  • Unrestricted Immigration and the Foreign Dominance Of
    Unrestricted Immigration and the Foreign Dominance of United States Nobel Prize Winners in Science: Irrefutable Data and Exemplary Family Narratives—Backup Data and Information Andrew A. Beveridge, Queens and Graduate Center CUNY and Social Explorer, Inc. Lynn Caporale, Strategic Scientific Advisor and Author The following slides were presented at the recent meeting of the American Association for the Advancement of Science. This project and paper is an outgrowth of that session, and will combine qualitative data on Nobel Prize Winners family histories along with analyses of the pattern of Nobel Winners. The first set of slides show some of the patterns so far found, and will be augmented for the formal paper. The second set of slides shows some examples of the Nobel families. The authors a developing a systematic data base of Nobel Winners (mainly US), their careers and their family histories. This turned out to be much more challenging than expected, since many winners do not emphasize their family origins in their own biographies or autobiographies or other commentary. Dr. Caporale has reached out to some laureates or their families to elicit that information. We plan to systematically compare the laureates to the population in the US at large, including immigrants and non‐immigrants at various periods. Outline of Presentation • A preliminary examination of the 609 Nobel Prize Winners, 291 of whom were at an American Institution when they received the Nobel in physics, chemistry or physiology and medicine • Will look at patterns of
    [Show full text]
  • COURSE CATALOG 2016-2017 Academic Calendar
    COURSE CATALOG 2016-2017 Academic Calendar . 4 Academic Programs . 46 About LACM . .. 6 Performance LACM Educational Programs . 8 Bass . 46 CONTENTS Administration . 10 Brass & Woodwind . .. 52 Admissions . 11 Drums . .. 58 Tuition & Fees . 13 Guitar . 64 Financial Aid . 18 Vocal. 70 Registrar . 22 Music Composition International Student Services . 26 Songwriting . 76 Academic Policies & Procedures . 27 Music Production Student Life . 30 Composing for Visual Media . 82 Career Services . .. 32 Music Producing & Recording . 88 Campus Facilities – Security. 33 Music Industry Rules of Conduct & Expectations . 35 Music Business . 94 Health Policies . 36 Course Descriptions . 100 Grievance Policy & Procedures . .. 39 Department Chairs & Faculty Biographies . 132 Change of Student Status Policies & Procedures . 41 Collegiate Articulation & Transfer Agreements . 44 FALL 2016 (OCTOBER 3 – DECEMBER 16) ACADEMIC DATES SPRING 2017 (APRIL 10 – JUNE 23) ACADEMIC DATES July 25 - 29: Registration Period for October 3 - October 7: Add/Drop January 30 - February 3: Registration Period for April 10 - April 14: Add/Drop Upcoming Quarter Upcoming Quarter October 10 - November 11: Drop with a “W” April 17 - May 19: Drop with a “W” August 22: Tuition Deadline for Continuing Students February 27: Tuition Deadline for November 14 - December 9: Receive a letter grade May 22 - June 16: Receive a letter grade October 3: Quarter Begins Continuing Students November 11: Veterans Day, Campus Closed April 10: Quarter Begins November 24: Thanksgiving, Campus Closed May 29: Memorial Day, Campus Closed November 25: Campus Open, No classes. June 19 - 23: Exams Week December 12-16: Exams Week June 23: Quarter Ends December 16: Quarter Ends December 24 - 25: Christmas, Campus Closed December 26: Campus Open, No classes.
    [Show full text]
  • The Truth About Fat: the Latest Update February 24Th 2016 Cathy Mazanec, MPH, RDN, CSSD, LDN
    The Truth about Fat: The Latest Update February 24th 2016 Cathy Mazanec, MPH, RDN, CSSD, LDN I recently attended a Fat Summit hosted by Integrative and Functional Medicine physician, Mark Hyman, MD, Director of the Center for Functional Medicine at the Cleveland Clinic. Dr. Hyman invited some of the most prestigious U.S. researchers to join this online Summit to share their individual research data. This academic bench of researchers and thought leaders was deep, some of whom included: Ronald Krause, MD; Daniel Amen, MD; Jeffrey Bland, PhD; Michael Roizen, MD; Chris Kresser, MS, LAc; Walter Willett, MD; David Perlmutter, MD; Dean Ornish, MD. I was so excited to finally hear the latest update about dietary fats and end the great fat debate once and for all. What a long awaited relief this would be…… This could not have been further from the truth!! Consistent with the pattern I’ve seen over my 37 year career, nutrition research from highly respected scholars often conflicts. The reason for this is each researcher is looking at a different piece of the same puzzle. In this case, the effect of a certain dietary fat on one piece of the puzzle may be very different from the effect that fat has on another piece of the puzzle. Hence, each researcher may have a different viewpoint and recommendation about the dietary fat being studied. So a lot of questions still remain unanswered but some information is very clear. Here's a snippet of the latest research regarding dietary fat and what we need to know ……….
    [Show full text]
  • The FTC Vs. POM Wonderful
    Daniels Fund Ethics Initiative University of New Mexico http://danielsethics.mgt.unm.edu Debate The FTC vs. POM Wonderful ISSUE: Does the Federal Trade Commission’s verdict on POM Wonderful’s advertising protect consumers or limit the company’s First Amendment rights? POM Wonderful, owned by philanthropists Lynda and Stewart Resnick, sells products made from pomegranate juice. Their product lines include juice, juice blends, teas, concentrates and extracts. Its most popular product is its POM 100% Juice. The company has marketed pomegranate juice for its high antioxidants, vitamin K, and potassium. Pomegranate juice has become popular among consumers who desire to improve their health. However, in 2010 the Federal Trade Commission (FTC) ruled that POM Wonderful used deceptive advertising. Among its marketing claims, POM Wonderful maintained that pomegranate juice lowers the risks of heart disease, erectile dysfunction, and prostate cancer. POM advertisements with claims such as “Amaze Your Cardiologist” and “Drink to Prostate Health” were placed in Parade, Fitness, and Fitness magazines; The New York Times; on price tags; and on the websites pomwonderful.com, pompills.com, and pomegranatetruth.com. The problem, according to the FTC, was that these claims were not substantiated. The FTC maintains that POM Wonderful based its claims on faulty evidence the company distorted and that was eventually refuted. POM Wonderful was found guilty of violating the Federal Trade Commission Act by making deceptive claims in 36 advertisements and promotions. The FTC accused POM of making unsubstantiated efficacy claims—or suggesting that the product works as advertised—as well as establishment claims—claims that a product’s benefits and superiority have been scientifically established.
    [Show full text]
  • 138904 02 Classic.Pdf
    breeders’ cup CLASSIC BREEDERs’ Cup CLASSIC (GR. I) 30th Running Santa Anita Park $5,000,000 Guaranteed FOR THREE-YEAR-OLDS & UPWARD ONE MILE AND ONE-QUARTER Northern Hemisphere Three-Year-Olds, 122 lbs.; Older, 126 lbs.; Southern Hemisphere Three-Year-Olds, 117 lbs.; Older, 126 lbs. All Fillies and Mares allowed 3 lbs. Guaranteed $5 million purse including travel awards, of which 55% of all monies to the owner of the winner, 18% to second, 10% to third, 6% to fourth and 3% to fifth; plus travel awards to starters not based in California. The maximum number of starters for the Breeders’ Cup Classic will be limited to fourteen (14). If more than fourteen (14) horses pre-enter, selection will be determined by a combination of Breeders’ Cup Challenge winners, Graded Stakes Dirt points and the Breeders’ Cup Racing Secretaries and Directors panel. Please refer to the 2013 Breeders’ Cup World Championships Horsemen’s Information Guide (available upon request) for more information. Nominated Horses Breeders’ Cup Racing Office Pre-Entry Fee: 1% of purse Santa Anita Park Entry Fee: 1% of purse 285 W. Huntington Dr. Arcadia, CA 91007 Phone: (859) 514-9422 To Be Run Saturday, November 2, 2013 Fax: (859) 514-9432 Pre-Entries Close Monday, October 21, 2013 E-mail: [email protected] Pre-entries for the Breeders' Cup Classic (G1) Horse Owner Trainer Declaration of War Mrs. John Magnier, Michael Tabor, Derrick Smith & Joseph Allen Aidan P. O'Brien B.c.4 War Front - Tempo West by Rahy - Bred in Kentucky by Joseph Allen Flat Out Preston Stables, LLC William I.
    [Show full text]
  • TOP GIFTS RECEIVED in L.A. COUNTY Architectural Firms, Business Improvement Ranked by Gift Value in 2018 the LIST Districts, Commercial Interior Designers
    10 LOS ANGELES BUSINESS JOURNAL JANUARY 21, 2019 NEXT WEEK TOP GIFTS RECEIVED IN L.A. COUNTY Architectural Firms, Business Improvement Ranked by gift value in 2018 THE LIST Districts, Commercial Interior Designers Rank Company Gift Value Description Donor • name • name • address • source of wealth • phone Cedars-Sinai Medical Center $50,000,000 create the Smidt Heart Institute Smidt Foundation 1 8700 Beverly Blvd. retail Los Angeles 90048 (800) 233-2771 Partnership for Los Angeles Schools 35,000,000 improve 18 identified public schools in the Los Angeles Richard Lundquist 2 1055 Wilshire Blvd., Suite 1850 Unified School District Melanie Lundquist Los Angeles 90017 real estate (213) 201-2000 University of California, Los Angeles Hammer Museum 30,000,000 capital campaign Stewart Resnick 3 10899 Wilshire Blvd. Lynda Resnick Los Angeles 90024 agriculture, food and beverage, (310) 443-7000 investments David Geffen School of Medicine at UCLA 25,000,000 establish the Laurie and Steven Gordon Commitment Steven Gordon Family Foundation 4 10833 Le Conte Ave. to Cure Parkinson's Disease law, real estate Los Angeles 90095 (310) 825-6373 University of California, Los Angeles 25,000,000 endow scholarships for graduate students in the Kenneth Panzer 405 Hilgard Ave. humanities Jordan Kaplan Los Angeles 90095 real estate (310) 825-4321 Oprah Winfrey Charitable Foundation 22,500,000 gift of Weight Watchers International Inc. stock Oprah Winfrey 6 1041 N. Formosa Ave. media and entertainment West Hollywood 90046 N/A Good Samaritan Hospital 21,000,000 expansion of the emergency department and fund Charles Munger 7 1225 Wilshire Blvd. seismic improvements to the hospital investments Los Angeles 90017 (213) 977-2121 Children's Hospital Los Angeles 20,000,000 renovate its emergency department, pay for new Anonymous 8 4650 Sunset Blvd.
    [Show full text]
  • Intensive Lifestyle Changes for Reversal of Coronary Heart Disease
    Intensive Lifestyle Changes for Reversal of Coronary Heart Disease Dean Ornish, MD; Larry W. Scherwitz, PhD; James H. Billings, PhD, MPH; K. Lance Gould, MD; Terri A. Merritt, MS; Stephen Sparler, MA; William T. Armstrong, MD; Thomas A. Ports, MD; Richard L. Kirkeeide, PhD; Charissa Hogeboom, PhD; Richard J. Brand, PhD Context.—The Lifestyle Heart Trial demonstrated that intensive lifestyle THE LIFESTYLE Heart Trial was the changes may lead to regression of coronary atherosclerosis after 1 year. first randomized clinical trial to investi- Objectives.—To determine the feasibility of patients to sustain intensive lifestyle gate whether ambulatory patients could changes for a total of 5 years and the effects of these lifestyle changes (without be motivated to make and sustain com- lipid-lowering drugs) on coronary heart disease. prehensive lifestyle changes and, if so, whether the progression of coronary Design.—Randomized controlled trial conducted from 1986 to 1992 using a atherosclerosis could be stopped or re- randomized invitational design. versed without using lipid-lowering Patients.—Forty-eight patients with moderate to severe coronary heart disease drugs as measured by computer-as- were randomized to an intensive lifestyle change group or to a usual-care control sisted quantitative coronary arteriogra- group, and 35 completed the 5-year follow-up quantitative coronary arteriography. phy. This study derived from earlier Setting.—Two tertiary care university medical centers. studies that used noninvasive mea- Intervention.—Intensive lifestyle changes (10% fat whole foods vegetarian diet, sures.1,2 aerobic exercise, stress management training, smoking cessation, group psycho- After 1 year, we found that experi- social support) for 5 years.
    [Show full text]
  • Marilyn Mccoo and Billy Davis
    FOR IMMEDIATE RELEASE December 7, 2019 CONTACT: DeAnn Lubell-Ames – (760) 831-3090 Note: Photos available at http://mccallumtheatre.com/index.php/media Marilyn McCoo And Billy Davis Jr.: Up, Up And Away McCallum Theatre Saturday – January 11 – 8:00pm Palm Desert, CA – The McCallum Theatre welcomes pop-soul greats Marilyn McCoo and Billy Davis Jr., who will be performing their Up, Up and Away show on Saturday, January 11, at 8:00pm. McCoo and Davis—who celebrated 50 years of marriage earlier this year—are the original lead singers of the legendary pop/R&B vocal group The 5th Dimension, producing iconic songs such as “Up, Up and Away,” “Aquarius/Let the Sunshine In,” “Worst That Could Happen,” “Stoned Soul Picnic,” “Sweet Blindness,” “Wedding Bell Blues” and “One Less Bell to Answer.” They left The 5th Dimension to strike out on their own—and they found instant success. In 1976, their album I Hope We Get to Love in Time topped the Billboard Hot 100 chart, and single “You Don’t Have to be a Star (to Be in My Show)” went to No. 1 and was honored with the Grammy Award for Best R&B Performance. In 1977, they hosted their own TV series on CBS. Marilyn McCoo later hosted the 1980s music countdown series Solid Gold. She’s also acted in numerous TV series and films. She made her mark on Broadway, most notably playing Julie in the revival of Showboat. Billy Davis went on to a successful gospel music career. He has also been featured on TV and film; McCoo and Davis had recurring roles together as parents on The Jamie Foxx Show.
    [Show full text]
  • Vegetarianism’ Is a Case for Returning to Our Essence As Beings Created in the Image and Likeness of God
    “This important pamphlet helps us advance the supreme Jewish goals of tikkun olam (healing and improving our world) and kiddush haShem (sanctifying the Divine Name).” —RABBI DAVID ROSEN, FORMER CHIEF RABBI OF IRELAND “The authors have powerfully united scientific and spiritual perspectives on why we—as Jews, as human beings, and as members of the global commons—should ‘go vegetarian.’” —RABBI FRED SCHERLINDER DOBB, COALITION ON THE ENVIRONMENT AND JEWISH LIFE A CASE FOR ‘“A Case for Jewish Vegetarianism’ is a case for returning to our essence as beings created in the image and likeness of God. It is a guide to be ... read and a guideline to be followed.” —RABBI RAMI M. SHAPIRO, SIMPLY JEWISH AND ONE RIVER FOUNDATION EWISH “Judaism … inspires and compels us to think before we eat. ‘A Case for J Jewish Vegetarianism’ provides many powerful reasons for us to be even VEGETARIANISM more compassionate through the foods we choose to consume.” —RABBI JONATHAN K. CRANE, HARVARD HILLEL “The case for Jewish vegetarianism is increasingly compelling, for ethical, environmental and health reasons--this provocative and important booklet makes that case lucidly from all three perspectives.” —RABBI BARRY SCHWARTZ, CENTRAL CONFERENCE OF AMERICAN RABBIS TASK FORCE ON KASHRUT FOR ANIMALS, FOR YOURSELF, AND FOR THE ENVIRONMENT People for the Ethical Treatment of Animals • GoVeg.com VEG314 1/05 RABBINIC STATEMENTS OF SUPPORT INTRODUCTION The Variety of Jewish Arguments for Vegetarianism “In contemporary society, more than ever before, vegetarianism should be an imperative Vegetarianism is becoming more and more popular in North for Jews who seek to live in accordance with Judaism’s most sublime teachings.
    [Show full text]
  • Facebook Timeline
    Facebook Timeline 2003 October • Mark Zuckerberg releases Facemash, the predecessor to Facebook. It was described as a Harvard University version of Hot or Not. 2004 January • Zuckerberg begins writing Facebook. • Zuckerberg registers thefacebook.com domain. February • Zuckerberg launches Facebook on February 4. 650 Harvard students joined thefacebook.com in the first week of launch. March • Facebook expands to MIT, Boston University, Boston College, Northeastern University, Stanford University, Dartmouth College, Columbia University, and Yale University. April • Zuckerberg, Dustin Moskovitz, and Eduardo Saverin form Thefacebook.com LLC, a partnership. June • Facebook receives its first investment from PayPal co-founder Peter Thiel for US$500,000. • Facebook incorporates into a new company, and Napster co-founder Sean Parker becomes its president. • Facebook moves its base of operations to Palo Alto, California. N. Lee, Facebook Nation, DOI: 10.1007/978-1-4614-5308-6, 211 Ó Springer Science+Business Media New York 2013 212 Facebook Timeline August • To compete with growing campus-only service i2hub, Zuckerberg launches Wirehog. It is a precursor to Facebook Platform applications. September • ConnectU files a lawsuit against Zuckerberg and other Facebook founders, resulting in a $65 million settlement. October • Maurice Werdegar of WTI Partner provides Facebook a $300,000 three-year credit line. December • Facebook achieves its one millionth registered user. 2005 February • Maurice Werdegar of WTI Partner provides Facebook a second $300,000 credit line and a $25,000 equity investment. April • Venture capital firm Accel Partners invests $12.7 million into Facebook. Accel’s partner and President Jim Breyer also puts up $1 million of his own money.
    [Show full text]
  • Person of the Year" Covers for Time Magazine
    UNLV Theses, Dissertations, Professional Papers, and Capstones 12-1-2012 Where in the World are the Women of Time? Women and the "Person of the Year" Covers for Time Magazine Krystle Lynne Anttonelli University of Nevada, Las Vegas Follow this and additional works at: https://digitalscholarship.unlv.edu/thesesdissertations Part of the Gender, Race, Sexuality, and Ethnicity in Communication Commons, Mass Communication Commons, and the Women's Studies Commons Repository Citation Anttonelli, Krystle Lynne, "Where in the World are the Women of Time? Women and the "Person of the Year" Covers for Time Magazine" (2012). UNLV Theses, Dissertations, Professional Papers, and Capstones. 1704. http://dx.doi.org/10.34917/4332685 This Thesis is protected by copyright and/or related rights. It has been brought to you by Digital Scholarship@UNLV with permission from the rights-holder(s). You are free to use this Thesis in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/ or on the work itself. This Thesis has been accepted for inclusion in UNLV Theses, Dissertations, Professional Papers, and Capstones by an authorized administrator of Digital Scholarship@UNLV. For more information, please contact [email protected]. WHERE ARE THE WOMEN OF TIME? WOMEN AND THE “PERSON OF THE YEAR” COVERS FOR TIME MAGAZINE by Krystle Anttonelli Bachelor
    [Show full text]
  • The Complex Life of the Complex Life Of
    The Complex Life of mRNA EMBO|EMBL Symposium 5–8 October 2016 Heidelberg | Germany EMBL Advanced Training Centre KEYNOTE SPEAKERS Thomas Cech Patrick Cramer Jennifer Doudna University of Colorado Boulder, USA MPI for Biophysical Chemistry, Germany University of California, Berkley, USA ABSTRACT SUBMISSION DEADLINE CONFIRMED SPEAKERS 13 JULY 2016 Maria Barna Rachel Green Shona Murphy Stanford University, USA Johns Hopkins University Sir William Dunn School of Pathology, UK School of Medicine, USA REGISTRATION DEADLINE Simon Bullock Karla Neugebauer 24 AUGUST 2016 MRC Laboratory of Molecular Biology, UK Chuan He Yale University, USA The University of Chicago, USA Emmanuelle Charpentier Uwe Ohler MPI for Infection Biology, Germany Alan Hinnebusch Max Delbrueck Center, Berlin, Germany ORGANISERS NIH, USA Anne Ephrussi Jeffrey Chao Laura Ranum EMBL Heidelberg, Germany Friedrich Miescher Institute for Elisa Izaurralde University of Florida, USA Biomedical Research, Switzerland MPI for Developmental Biology, Germany Nahum Sonenberg Erin Schuman McGill University, Canada Elena Conti Jeff Kieft MPI for Brain Research, Germany MPI of Biochemistry, Germany University of Colorado, USA Joan Steitz Yukihide Tomari Yale University, USA Victoria D'Souza Iain MacRae The University of Tokyo, Japan Harvard University, USA The Scripps Research Institute, USA David Tollervey Jonathan Weissman Wellcome Trust Centre for Cell Biology, UK Caroline Dean James Manley University of California, John Innes Centre, UK Columbia University, USA San Francisco, USA Additional speakers will be Gideon Dreyfuss Christine Mayr Marat Yusupov selected from abstracts. Perelman School of Medicine at the Memorial Sloan Kettering Cancer Institute of Genetics and Molecular University of Pennsylvania, USA Center, USA and Cellular Biology (IGBMC), France CONTACT www.embo-embl-symposia.org [email protected].
    [Show full text]